Suppr超能文献

壳聚糖纳米粒疫苗免疫接种可预防肉鸡感染肠炎沙门氏菌。

Salmonella chitosan nanoparticle vaccine administration is protective against Salmonella Enteritidis in broiler birds.

机构信息

Department of Poultry Science, The University of Georgia, Athens, Georgia, United States of America.

Department of Veterinary Preventative Medicine, Center for Food Animal Health, Ohio Agricultural Research and Development Center, The Ohio State University, Columbus, Ohio, United States of America.

出版信息

PLoS One. 2021 Nov 16;16(11):e0259334. doi: 10.1371/journal.pone.0259334. eCollection 2021.

Abstract

Salmonella control strategies include vaccines that help reduce the spread of Salmonella in poultry flocks. In this study we evaluated the efficacy of administering a live Salmonella vaccine followed by a killed Salmonella chitosan nanoparticle (CNP) vaccine booster on the cellular and humoral immunity of broilers. The CNP vaccine was synthesized with Salmonella Enteritidis (S. Enteritidis) outer-membrane-proteins (OMPs) and flagellin-proteins. At d1-of-age, one-hundred-sixty-eight chicks were allocated into treatments: 1) No vaccine, 2) Live vaccine (Poulvac®ST), 3) CNP vaccine, 4) Live+CNP vaccine. At d1-of-age, birds were orally vaccinated with PBS, Live vaccine, or CNP. At d7-of-age, the No vaccine, Live vaccine and CNP vaccine groups were boosted with PBS and the Live+CNP vaccine group was boosted with CNP. At d14-of-age, birds were challenged with 1×109 CFU/bird S. Enteritidis. There were no significant differences in body-weight-gain (BWG) or feed-conversion-ratio (FCR). At 8h-post-challenge, CNP and Live+CNP-vaccinated birds had 17% and 24% greater levels (P<0.05) of anti-Salmonella OMPs IgA in bile, respectively, compared to control. At d28-of-age, CNP, Live, and Live+CNP-vaccinated birds had 33%, 18%, and 24% greater levels (P<0.05) of anti-Salmonella OMPs IgA in bile, respectively, compared to control. At d14-of-age, Live+CNP-vaccinated birds had 46% greater levels (P<0.05) of anti-Salmonella OMPs IgY in serum, compared to control. At d21-of-age, splenocytes from CNP and Live-vaccinated birds had increased (P<0.05) T-lymphocyte proliferation at 0.02 mg/mL OMPs stimulation compared to the control. At d28-of-age, CNP and Live+CNP-vaccinated birds had 0.9 Log10 CFU/g and 1 Log10 CFU/g decreased S. Enteritidis cecal loads (P<0.05), respectively, compared to control. The CNP vaccine does not have adverse effects on bird's BWG and FCR or IL-1β, IL-10, IFN-γ, or iNOS mRNA expression levels. It can be concluded that the CNP vaccine, as a first dose or as a booster vaccination, is an alternative vaccine candidate against S. Enteritidis in broilers.

摘要

沙门氏菌控制策略包括有助于减少家禽群中沙门氏菌传播的疫苗。在这项研究中,我们评估了在肉鸡中接种活沙门氏菌疫苗后再接种死沙门氏菌壳聚糖纳米颗粒(CNP)疫苗加强针对细胞和体液免疫的功效。CNP 疫苗是用沙门氏菌肠炎(S. Enteritidis)的外膜蛋白(OMPs)和鞭毛蛋白合成的。在 1 日龄时,将 168 只小鸡分配到以下处理组:1)无疫苗,2)活疫苗(Poulvac®ST),3)CNP 疫苗,4)活疫苗+CNP 疫苗。在 1 日龄时,鸡通过口服接种 PBS、活疫苗或 CNP 进行免疫。在 7 日龄时,无疫苗、活疫苗和 CNP 疫苗组用 PBS 进行加强免疫,活疫苗+CNP 疫苗组用 CNP 进行加强免疫。在 14 日龄时,鸡用 1×109 CFU/只的肠炎沙门氏菌进行攻毒。体重增加(BWG)或饲料转化率(FCR)没有显著差异。在攻毒后 8 小时,与对照组相比,CNP 和活疫苗+CNP 疫苗接种组的胆汁中抗沙门氏菌 OMPs IgA 水平分别增加了 17%和 24%(P<0.05)。在 28 日龄时,与对照组相比,CNP、活疫苗和活疫苗+CNP 疫苗接种组的胆汁中抗沙门氏菌 OMPs IgA 水平分别增加了 33%、18%和 24%(P<0.05)。在 14 日龄时,与对照组相比,活疫苗+CNP 疫苗接种组的血清中抗沙门氏菌 OMPs IgY 水平增加了 46%(P<0.05)。在 21 日龄时,与对照组相比,CNP 和活疫苗组的脾细胞在 0.02 mg/mL OMP 刺激下的 T 淋巴细胞增殖增加(P<0.05)。在 28 日龄时,与对照组相比,CNP 和活疫苗+CNP 疫苗接种组的鸡盲肠沙门氏菌载量分别降低了 0.9 Log10 CFU/g 和 1 Log10 CFU/g(P<0.05)。CNP 疫苗对鸡的 BWG 和 FCR 或 IL-1β、IL-10、IFN-γ或 iNOS mRNA 表达水平没有不良影响。可以得出结论,CNP 疫苗作为首剂或加强疫苗接种,是肉鸡抗肠炎沙门氏菌的一种替代疫苗候选物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbb6/8594846/6095164b2dca/pone.0259334.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验